UTHR vs WES · P/E 20, rev $1.56B vs P/E 12, rev $3.84B
United Therapeutics Corporation (UTHR) versus Western Midstream Partners LP (WES) — a side-by-side from cached financials, not a winner call.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Western Midstream Partners LP (WES) is a oil & gas midstream company listed on US.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Latest reported WES revenue for 2025-12-31 was $3.84B. Net income was $1.18B. Revenue was up 6.6% from 2024-12-31 to 2025-12-31. WES currently screens at market cap $14.85B and trailing P/E 11.7.
UTHR currently screens at market cap $23.41B and trailing P/E 20.4. WES currently screens at market cap $14.85B and trailing P/E 11.7.
Not investment advice. Open the UTHR and WES stock pages for the full models.
Not investment advice.